Neue Zielerkrankungen im Neugeborenenscreening
- 15 February 2015
- journal article
- Published by Springer Science and Business Media LLC in Monatsschrift Kinderheilkunde
- Vol. 163 (2), 142-149
- https://doi.org/10.1007/s00112-014-3297-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Propionic acidemia: neonatal versus selective metabolic screeningJournal of Inherited Metabolic Disease, 2011
- Neonatal Screening for Metabolic and Endocrine DisordersDeutsches Ärzteblatt international, 2011
- Determination of Total Homocysteine, Methylmalonic Acid, and 2-Methylcitric Acid in Dried Blood Spots by Tandem Mass SpectrometryClinical Chemistry, 2010
- Combined Newborn Screening for Succinylacetone, Amino Acids, and Acylcarnitines in Dried Blood SpotsClinical Chemistry, 2008
- Reduction of the false‐positive rate in newborn screening by implementation of MS/MS‐based second‐tier tests: The Mayo Clinic experience (2004–2007)Journal of Inherited Metabolic Disease, 2007
- Rapid 2nd-Tier Test for Measurement of 3-OH-Propionic and Methylmalonic Acids on Dried Blood Spots: Reducing the False-Positive Rate for Propionylcarnitine during Expanded Newborn Screening by Liquid Chromatography–Tandem Mass SpectrometryClinical Chemistry, 2007
- Neue Screening-RichtlinienMonatsschrift Kinderheilkunde, 2002